INTRODUCTION
Liver cirrhosis is often accompanied by portal hypertension, which often manifests as esophageal varices, ascites, splenomegaly, hypersplenism, upper gastrointestinal hemorrhage, portosystemic shunt encephalopathy, and spontaneous bacterial peritonitis [1] . Spontaneous portosystemic shunt (SPSS), a common but insufficient clinical manifestation, is a result of compensation of portal hypertension in cirrhosis [2] . The shunt can be congenital or acquired [3] . The incidence rate of SPSS in patients with cirrhosis is 38%-40%, and the incidence rate of splenorenal shunt (SRS) is 14%-21% [4] . The most common types of SPSS are SRS and umbilical vein recanalization [5] . Rare types include collateral veins in gastric varices, gallbladder varices, thrombotic portal vein (PV), intestinal-caval shunt, and right portal-renal vein shunt [6] . Spontaneous intrahepatic portosystemic shunt (SPISS), a rare SPSS type, includes PV branches that directly shunt to the intrahepatic vein and PV branches that shunt to the extrahepatic inferior vena cava (IVC).
We recently encountered a 66-year-old woman with a 20-year history of hepatitis B surface antigen (HBsAg) positivity. We found that she had an extremely rare SPISS, a spontaneous intrahepatic PV-IVC shunt (SPIVCS) caused by portal hypertension.
CASE PRESENTATION

Chief complaints
A 66-year-old woman was admitted to our hospital with the complaint of a 1-mo history of abdominal distention and decreased appetite.
History of present illness
She had no history of ascites, gastrointestinal bleeding, or hepatic encephalopathy. She had no history of alcohol abuse or hepatitis C.
History of past illness
The patient also had a 20-year history of HBsAg positivity and had been treated with Chinese herbal medicine for a long time. In the past 5 years, she had been diagnosed with cirrhosis induced by hepatitis B by a rural doctor.
Personal and family history
No alcohol abuse and no other drug and herbal used. No additional family history. While her daughter had history of HBsAg positivity but no history of hereditary diseases.
Physical examination upon admission
A physical examination revealed a blood pressure of 135/82 mmHg, heart rate of 78 beats/min, temperature of 36.8°C, and breathing rate of 18 times/min. Her skin was dark and gloomy; no yellowing of the skin and mucosa was evident; visible liver palms and spider angioma, an abdominal bulge, and visible abdominal wall vein exposure were evident, and splenomegaly (4 cm below the left midclavicular line-left ribs junction) were evident; no abdominal pain was reported; and the ascites buckle sign was positive.
Laboratory examinations
Routine bloodwork revealed the following: red blood cell count, 2.13 × 10 9 /L; hemoglobin, 6.12 g/L; white blood cell count, 2.43 × 10 9 /L; neutrophil count, 1.86 × 10 9 /L; and platelet count, 5.25 × 10 12 /L. Liver function test results were as follows: alanine aminotransferase, 35 U/L (10-40 U/L); aspartate aminotransferase, 42 U/L (10-40 U/L); serum total bilirubin, 17.2 µmol/L (1.71-17.1 µmol/L); direct bilirubin, 4.26 µmol/L (0-6.8 µmol/L); serum albumin (ALB), 32.2 g/L (35-53 g/L); serum globulin 28 g/L (20-40 g/L); alkaline phosphatase, 89 U/L (40-120 U/L); glutamide transphthalase, 63 U/L (10-40 U/L); and serum ammonia, 45 µmol/L (27-82 µmol/L). Hepatitis B virus (HBV) markers were as follows: HBsAg, 26 IU/mL (< 0.05 IU/mL); anti-HBs, 0.001 mIU/mL (< 10 mIU/mL); anti-hepatitis B e antigen, 2.143 Paul Ehrlich international units (PEIU)/mL (< 0.2 PEIU/mL); anti-hepatitis B core antigen, 3.221 PEIU/mL (< 0.9 PEIU/mL).
Other results were as follows: HBV DNA, not detected (< 20 IU/mL); alpha fetoprotein, 4.25 µg/L (< 20 ng/mL); ascites examination, clear; Li Fanta test, negative; nucleated cell count, 0.82 × 10 9 /L; monocyte ratio, 55%; polymorphonuclear cell ratio, 45%; and serum ascites ALB gradient, 25.2 g/L.
Antinuclear antibody, anti-smooth muscle antibody, anti-liver/kidney microsome antibody type 1, anti-nuclear glycoprotein antibody, anti-soluble acid nucleoprotein antibody, soluble acidic nucleoprotein antibody, anti-hepatocyte cytoplasmic antigen type 1 antibody, anti-soluble liver antigen/hepatopancreatic antigen antibody, and other tests were negative. Other levels were: immunoglobulin G (IgG), 13.1 g/L (7.11-16 g/L); IgG4, 0.08 g/L (≤ 2.01 g/L); and ceruloplasmin, 0.33 g/L (0.2-0.6 g/L).
Imaging examinations
Abdominal ultrasonography revealed that echoes of the liver showed dense thickening and an uneven intrahepatic structure disorder; the liver capsule was unclear and irregular. The right branch of the PV showed obvious dilatation (local dilatation, up to 48 mm), was connected with the IVC, and showed a turbulent local spectrum, as shown in Figure 1 .
Abdomen enhanced computed tomography (CT) revealed that the left branch of the PV was thin and occluded, while the right branch of the PV was thick, showed a vermicular dilatation vein cluster, branched out, and converged into the IVC from the bare area of the lower right posterior lobe of the liver, forming a venous dilatation vein cluster in the upper pole of the right kidney (Figure 2 and 3 ). In addition, a vermicular dilatation vein shadow was seen in the inner wall of the lower esophagus, perineural space, and hepatic-gastric space and the splenic vein diameter was increased to 1.7 cm. A portion of the liver lobe was disordered and the hepatic fissure was widened. The spleen was enlarged and numerous liquid shadows were visible in the abdominal cavity.
FINAL DIAGNOSIS
A rare SPISS in hepatitis B-induced cirrhosis.
TREATMENT
After admission, 3000 mL of ascites fluid was drained, 20 g of human ALB was intravenously infused, and 100 mg of spironolactone and 40 mg of furosemide were administered per day. One week later, the abdominal distension was relieved, her appetite improved, and she was discharged with maintenance therapy of propranolol 20 mg/d.
OUTCOME AND FOLLOW-UP
Follow-up of liver function and ultrasonography every 3 mo after discharge showed no further deterioration of liver function and ascites.
DISCCUSION
The portosystemic shunt is the pathway between the PV and the systemic circulation [7] . By etiology, it can be divided into congenital and spontaneous types [8] as well as intrahepatic and extrahepatic types according to anatomical location [9] .
SPISS is a spontaneous venous pathway that extends from the intrahepatic venous system to the circular venous system [10] . It is mostly acquired, but a congenital type has not been identified [11] . Lalonde et al [12] reported a SPIVCS case which may be belong to the congenital type because the patient was only a 15-year-old adolescent with no evidence of liver cirrhosis or portal hypertension. There are still two types of SPISS: one in which the intrahepatic PV branch shunts to the intrahepatic vein, and another in which the intrahepatic PV shunts to the IVC through the lateral hepatic branch. The first type can occur in cases of tumors, liver trauma, or Budd-Chiari syndrome (BCS) [13, 14] . The second type is very rarely discussed and refers to the right posterior branch of the PV connected with the IVC through the right posterior lobe of the liver in the right adrenal region. SPIVCS is common in cirrhosis patients with portal hypertension. Its possible anatomical basis is that the right branch of the PV communicates with the IVC through the accessory hepatic vein or the subcapsular venous plexus of the liver. Since there is no standard proper term to describe this type of shunt, we refer to it as SPIVCS.
Abernethy malformation is also a SPSS that requires differentiation from SPISS, a rare congenital extrahepatic portosystemic shunt malformation caused by abnormal development of the PV system [15] . Morgan and Supefina classified Abernethy malformations as follows [16] : type I, complete portosystemic shunt without PV perfusion in the liver; and type II, partial portosystemic shunt with partial portosystemic blood perfusion in the liver. Type I primarily affects children and women and is often accompanied by other congenital malformations such as biliary atresia, polysplenoma, heart defects, and liver tumors. Type II is rarer, primarily affects men, and features few other congenital malformations. Moreover, Abernethy malformation has no underlying diseases such as cirrhosis or portal hypertension and primarily affects children [17] .
We retrieved the PubMed database using "intrahepatic portosystemic shunt," "intrahepatic portal cavity shunt," "spontaneous intrahepatic portosystemic shunt," and "portoinferior vena cava shunt" keywords and MeSH terms, respectively. By January 31, 2019, six articles describing intrahepatic SPSS similar to ours were found, as shown in Table 1 .
During liver transplantation for severe hepatic encephalopathy, Vennarecci [18] found a very thick shunt between the right branch of the PV and IVC, which made the operation more difficult. The shunt vein was torn during the operation, causing a massive hemorrhage. After hemostasis was achieved, the surgical strategy was changed to hepatectomy from the left side to the right side. Therefore, the SPIVCS shunt will increase the liver transplantation difficulty. Another SPISS type, which involves the PV branches directly shunting to the intrahepatic vein, can be caused by intrahepatic tumors and trauma or occur spontaneously [19] .
BCS characterized by obstructive lesions of the hepatic vein and the IVC is another cause of SPISS that is shunted to the vena cava system via the subcapsular or intrahepatic veins [14] . The use of a transjugular intrahepatic portosystemic shunt is an effective treatment for BCS-induced SPISS.
Kwon et al [10] reported a case of laparoscopic surgery used to circumcise the inflow of varicose veins. Their patient's hepatic encephalopathy improved postoperatively and liver function returned to normal. No shunt reappeared on a CT scan 8 mo later. [14] China 
